|
GB725228A
(en)
|
1952-06-19 |
1955-03-02 |
Roche Products Ltd |
Substituted carbamic acid esters and process for the manufacture thereof
|
|
BE640616A
(https=)
|
1962-12-19 |
|
|
|
|
NL130759C
(https=)
|
1965-10-07 |
|
|
|
|
US3492397A
(en)
|
1967-04-07 |
1970-01-27 |
Warner Lambert Pharmaceutical |
Sustained release dosage in the pellet form and process thereof
|
|
US4060598A
(en)
|
1967-06-28 |
1977-11-29 |
Boehringer Mannheim G.M.B.H. |
Tablets coated with aqueous resin dispersions
|
|
US3538214A
(en)
|
1969-04-22 |
1970-11-03 |
Merck & Co Inc |
Controlled release medicinal tablets
|
|
US4173626A
(en)
|
1978-12-11 |
1979-11-06 |
Merck & Co., Inc. |
Sustained release indomethacin
|
|
US4593034A
(en)
|
1984-04-06 |
1986-06-03 |
A. H. Robins Company, Inc. |
2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
AU611976B2
(en)
|
1987-12-24 |
1991-06-27 |
John Wyeth & Brother Limited |
Aroyl urea and carbamic acid derivatives of azabicyclo compounds
|
|
DE3878235T2
(de)
|
1988-08-04 |
1993-06-03 |
Synthelabo |
Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
|
|
US5549892A
(en)
|
1988-12-23 |
1996-08-27 |
Genzyme Corporation |
Enhanced in vivo uptake of glucocerebrosidase
|
|
US5236838A
(en)
|
1988-12-23 |
1993-08-17 |
Genzyme Corporation |
Enzymatically active recombinant glucocerebrosidase
|
|
IT1228293B
(it)
|
1989-02-06 |
1991-06-07 |
Angeli Inst Spa |
Benzoderivati di composti eterociclici contenenti azoto.
|
|
DK443489D0
(da)
|
1989-09-08 |
1989-09-08 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
|
US5272071A
(en)
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
|
GB9106571D0
(en)
|
1991-03-27 |
1991-05-15 |
Erba Carlo Spa |
Derivatives of substituted imidazol-2-one and process for their preparation
|
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
DE4326510A1
(de)
|
1993-08-06 |
1995-02-09 |
Bayer Ag |
Verfahren zur Herstellung von Cyclohexen-Derivaten
|
|
AU685225B2
(en)
|
1994-02-10 |
1998-01-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel carbamate derivative and medicinal composition containing the same
|
|
JPH08198751A
(ja)
|
1995-01-19 |
1996-08-06 |
Yamanouchi Pharmaceut Co Ltd |
カルバメート誘導体
|
|
KR19990067403A
(ko)
|
1995-11-08 |
1999-08-16 |
이곤 이 버그 |
1-아자바이시클로헵탄 유도체 및 이의 약제학적용도
|
|
SE9600683D0
(sv)
|
1996-02-23 |
1996-02-23 |
Astra Ab |
Azabicyclic esters of carbamic acids useful in therapy
|
|
JP2000515881A
(ja)
|
1996-07-29 |
2000-11-28 |
フアーマシア・アンド・アツプジヨン・アー・ベー |
アリールシクロアルカンカルボン酸エステル、その使用、薬剤組成物および調製
|
|
IL135578A0
(en)
|
1997-10-29 |
2001-05-20 |
Genzyme Corp |
Compositions and methods for treating lysosomal storage disease
|
|
US5985836A
(en)
|
1998-07-31 |
1999-11-16 |
Bayer Corporation |
Alpha-1 proteinase inhibitor binding peptides
|
|
US6468998B1
(en)
|
1998-11-02 |
2002-10-22 |
Mitsubishi Pharma Corporation |
Pyrrolidine compounds and medicinal utilization thereof
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
AU4038000A
(en)
|
1999-03-29 |
2000-10-16 |
Neurogen Corporation |
4-substituted quinoline derivatives as gaba receptor ligands
|
|
FR2791678B1
(fr)
|
1999-03-30 |
2001-05-04 |
Synthelabo |
Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
|
|
KR20020084116A
(ko)
|
2000-02-07 |
2002-11-04 |
애보트 게엠베하 운트 콤파니 카게 |
2-벤조티아졸릴 우레아 유도체 및 이의 단백질 키나제억제제로서의 용도
|
|
GB0010955D0
(en)
|
2000-05-05 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
|
KR100751981B1
(ko)
|
2000-06-27 |
2007-08-28 |
라보라토리오스 살바트, 에스.에이. |
아릴알킬아민으로부터 유도된 카바메이트
|
|
US6896896B2
(en)
|
2000-07-19 |
2005-05-24 |
Unitika Ltd. |
Physiologically functional foods or cosmetics containing sphingoglycolipids and processes for their production
|
|
AU2001284645A1
(en)
|
2000-08-18 |
2002-03-04 |
Pharmacia And Upjohn Company |
Quinuclidine-substituted aryl compounds for treatment of disease
|
|
US6599916B2
(en)
|
2000-08-21 |
2003-07-29 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
|
NZ526580A
(en)
|
2000-12-22 |
2005-04-29 |
Almirall Prodesfarma Ag |
Quinuclidine carbamate derivatives and their use as M3 antagonists
|
|
ATE348829T1
(de)
|
2001-02-06 |
2007-01-15 |
Pfizer Prod Inc |
Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
|
|
JP2003267977A
(ja)
|
2002-03-14 |
2003-09-25 |
Yamanouchi Pharmaceut Co Ltd |
キヌクリジン誘導体
|
|
DE10211415A1
(de)
|
2002-03-15 |
2003-09-25 |
Bayer Ag |
Bicyclische N-Biarylamide
|
|
ES2203327B1
(es)
|
2002-06-21 |
2005-06-16 |
Almirall Prodesfarma, S.A. |
Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
AU2003246942B2
(en)
|
2002-07-17 |
2009-06-25 |
Idorsia Pharmaceuticals Ltd |
Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
|
|
JPWO2004011430A1
(ja)
|
2002-07-25 |
2005-11-24 |
アステラス製薬株式会社 |
ナトリウムチャネル阻害剤
|
|
SE0202430D0
(sv)
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
JP4750421B2
(ja)
|
2002-12-06 |
2011-08-17 |
ノース ショア−ロング アイランド ジュ−イッシュ リサ−チ インスティチュ−ト |
α７受容体結合コリン作動性アゴニストを用いる炎症の阻害
|
|
WO2004056744A1
(en)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
|
|
US20050031683A1
(en)
|
2003-08-04 |
2005-02-10 |
Ashish Kapoor |
Solid pharmaceutical composition
|
|
TW200529860A
(en)
|
2003-12-22 |
2005-09-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
JP2007186422A
(ja)
|
2004-01-28 |
2007-07-26 |
Astellas Pharma Inc |
アリールスルフィド誘導体
|
|
JP2008504282A
(ja)
|
2004-06-23 |
2008-02-14 |
ザ ファインスタイン インスティテュート フォー メディカル リサーチ |
コリンレセプターの薬理活性により腸閉塞を処置する方法
|
|
EP1811991B1
(en)
|
2004-11-10 |
2018-11-07 |
Genzyme Corporation |
Treatment of type 2 diabetes using inhibitors of glycosphingolipid synthesis
|
|
JP2008545776A
(ja)
|
2005-06-11 |
2008-12-18 |
ヴァーナリス アールアンドディー リミテッド |
癌および自己免疫疾患の治療における使用のためのピラゾール−置換ベンズイミダゾール誘導体
|
|
CN101312968A
(zh)
|
2005-09-23 |
2008-11-26 |
记忆药物公司 |
吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途
|
|
SG131819A1
(en)
|
2005-11-07 |
2007-05-28 |
Chikka Pte Ltd |
Buddy-based cross-carrier messaging system
|
|
WO2007083978A1
(en)
|
2006-01-23 |
2007-07-26 |
Crystalgenomics, Inc. |
Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same
|
|
EP1976519A2
(en)
|
2006-01-27 |
2008-10-08 |
Yale University |
Cytisine and acetylcholine analogs and methods of treating mood disorders
|
|
US7840109B2
(en)
|
2006-08-14 |
2010-11-23 |
Adc Telecommunications, Inc. |
Factory spliced cable assembly
|
|
EP2119716A4
(en)
|
2007-02-09 |
2011-06-01 |
Astellas Pharma Inc |
AZA BRIDGE CYCLE COMPOUND
|
|
KR101112110B1
(ko)
|
2007-03-09 |
2012-04-12 |
주식회사 녹십자 |
파킨슨병 예방 또는 치료용의 (+)-3-하이드록시모르피난의 경구적으로 생체이용가능한 전구약물
|
|
MX2009010557A
(es)
|
2007-03-30 |
2009-11-19 |
Amicus Therapeutics Inc |
Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas.
|
|
EP2170065A4
(en)
|
2007-06-20 |
2011-11-23 |
Merck Sharp & Dohme |
DIPHENYL SUBSTITUTED ALKANES
|
|
CA2706727A1
(en)
|
2007-11-29 |
2009-06-11 |
Michael S. Mcgrath |
Compositions and methods for treating lysosomal disorders
|
|
CA2731685A1
(en)
|
2008-07-28 |
2010-02-04 |
Genzyme Corporation |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
|
|
EP2154136A1
(en)
|
2008-08-08 |
2010-02-17 |
CHIESI FARMACEUTICI S.p.A. |
Quinuclidine carbonate derivatives and medicinal compositions thereof
|
|
WO2010091104A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Glucosylceramide synthase inhibitors
|
|
WO2010091164A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Inhibitors of glucosylceramide synthase
|
|
WO2010121963A1
(en)
|
2009-04-21 |
2010-10-28 |
Nerviano Medical Sciences S.R.L. |
Resorcinol derivatives as hsp90 inhibitors
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
EP2959902A1
(en)
|
2009-07-23 |
2015-12-30 |
Novartis AG |
Use of azabicycloalkyl derivatives for the treatment or prevention of ataxia
|
|
SI3998078T1
(sl)
|
2009-08-28 |
2026-02-27 |
Genzyme Corporation |
Encimsko nadomestno zdravljenje z naraščajočim odmerkom za zdravljenje pomanjkanja kisle sfingomielinaze
|
|
US20110183938A1
(en)
|
2009-12-16 |
2011-07-28 |
Genentech, Inc. |
1,7-diazacarbazoles and methods of use
|
|
ES2709487T3
(es)
|
2010-05-10 |
2019-04-16 |
Lesvi Laboratorios Sl |
Formulaciones farmacéuticas estables que contienen un antihistamínico
|
|
RU2436782C1
(ru)
|
2010-06-10 |
2011-12-20 |
Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) |
2-МЕТОКСИ-4[(3aR,7aS)-3,3,6-ТРИМЕТИЛ-1,3,3a,4,5,7a-ГЕКСАГИДРО-2-БЕНЗОФУРАН-1-ИЛ]ФЕНОЛ - НОВОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ ПАРКИНСОНА
|
|
KR101500915B1
(ko)
|
2010-11-12 |
2015-03-10 |
시오노기세야쿠 가부시키가이샤 |
6,7-불포화-7-카르바모일 모르피난 유도체의 결정 및 그의 제조 방법
|
|
KR101987736B1
(ko)
|
2011-03-18 |
2019-06-11 |
젠자임 코포레이션 |
글루코실세라마이드 합성효소 억제제
|
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
US20140228575A1
(en)
|
2011-06-22 |
2014-08-14 |
Isochem |
Process for the Preparation of Solifenacin and Salts Thereof
|
|
US9655946B2
(en)
|
2012-09-11 |
2017-05-23 |
Hospira Australia Pty Ltd. |
Daptomycin formulations and uses thereof
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
JO3713B1
(ar)
|
2013-03-15 |
2021-01-31 |
Genzyme Corp |
أشكال ملح (s)-كوينوكليدين-3-يل(2-(2-(4-فلوروفينيل)ثيازول-4-يل)بروبان-2-يل)كارباميت
|
|
MX365464B
(es)
|
2013-03-15 |
2019-06-04 |
Genzyme Corp |
Prodecimiento para preparar inhibidores de la glucosilceramida sintasa.
|
|
EP3079695B1
(en)
|
2013-12-11 |
2021-03-17 |
Genzyme Corporation |
Glucosylceramide synthase inhibitors
|
|
TW201642855A
(zh)
|
2015-03-10 |
2016-12-16 |
健臻公司 |
用於治療蛋白質病變之方法
|
|
MX2018006250A
(es)
*
|
2015-11-18 |
2018-09-05 |
Genzyme Corp |
Biomarcador de enfermedad poliquistica renal y usos del mismo.
|
|
EP3412296B1
(en)
|
2016-02-05 |
2025-11-12 |
Kyungpook National University Industry-Academic Cooperation Foundation |
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
|
|
EP3452045A1
(en)
|
2016-05-04 |
2019-03-13 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
EP3318277A1
(en)
|
2016-11-04 |
2018-05-09 |
Institut du Cerveau et de la Moelle Epiniere-ICM |
Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases
|
|
US10588888B2
(en)
*
|
2017-07-17 |
2020-03-17 |
Children's Hospital Medical Center |
CNS-accessible pharmacological chaperones for treatment of acid β-glucosidase-related disease states
|
|
US12472144B2
(en)
|
2017-08-08 |
2025-11-18 |
Amneal Pharmaceuticals Llc |
Pharmaceutical composition comprising eliglustat
|
|
US10519157B2
(en)
|
2018-02-09 |
2019-12-31 |
X-Cutag Therapeutics, Inc. |
Deuterated compounds for treating Fabry, Gaucher, Parkinson's and related diseases and conditions, and compositions and methods thereof
|
|
CN114040762A
(zh)
|
2019-02-04 |
2022-02-11 |
建新公司 |
使用葡糖神经酰胺合酶(gcs)的抑制剂治疗纤毛疾病
|
|
CN113395964A
(zh)
|
2019-02-04 |
2021-09-14 |
普瑞尼亚神经治疗有限公司 |
用于帕金森氏病和与帕金森症相关的其它疾病的低剂量普利多匹定
|
|
CN113645969A
(zh)
|
2019-02-04 |
2021-11-12 |
建新公司 |
用于治疗与溶酶体贮积症相关的症状和病症的方法
|
|
WO2021061701A1
(en)
|
2019-09-25 |
2021-04-01 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of lucerastat salts and process for preparation thereof
|
|
JP2023512366A
(ja)
|
2020-02-03 |
2023-03-27 |
ジェンザイム・コーポレーション |
リソソーム蓄積性疾患と関連する神経学的症状を処置するための方法
|
|
AU2021311131B2
(en)
|
2020-07-24 |
2026-02-19 |
Genzyme Corporation |
Pharmaceutical compositions comprising venglustat
|
|
US20230372313A1
(en)
|
2020-07-30 |
2023-11-23 |
Genzyme Corporation |
Methods for reducing glycosphingolipid concentration in brain tissue and methods of treatment of neurodegenerative diseases involving the same
|